Test_Prep
USMLE · Question #511
USMLE Question #511: Real Exam Question with Answer & Explanation
Sign in or unlock USMLE to reveal the answer and full explanation for question #511. The question stem and answer options stay visible for context.
Question
Over 1 year, a study is conducted to assess the antileukemic activity of a new tyrosine kinase inhibitor in patients with chronic myeloid leukemia in blast crisis. All patients enrolled in the study are informed that they would be treated with the tyrosine kinase inhibitor. They are assigned to successive dose cohorts of 300 to 1000 mg/day of the drug. Six to eight patients are assigned to each dose. Treatment efficacy is determined based on the results of complete blood counts and bone marrow assessments conducted regularly throughout the study. This study is best described as which of the following?
Options
- ACase-control study
- BCrossover study
- COpen-labeled clinical trial
- DRandomized clinical trial
- ESingle-blind, randomized, controlled trial
Unlock USMLE to see the answer
You've previewed enough free USMLE questions. Unlock USMLE for full answers, explanations, the timed quiz mode, progress tracking, and the master PDF. Question stem and options stay visible so you can still see what's on the exam.